ARTICLE | Clinical News
Deramciclane: Phase III
February 24, 2003 8:00 AM UTC
The companies discontinued development of deramciclane to treat GAD after combined results from 3 U.S. and European Phase III studies failed to show efficacy. The companies said the compound showed ef...